Authors


Megan E. Uehling, MD

Latest:

Barriers to Health Care Transition in Adolescents and Young Adults With Early Acquired HIV Infection

Unique challenges can affect the success of the shift from pediatric to adult care settings.


Sahil Khanna, MBBS, MS

Latest:

Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile Infections

To close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.


Christine Slover PharmD

Latest:

Shionogi's Strategies for Addressing Antibiotic Efficacy and Resistance

Christine Slover, PharmD discussed cefiderocol's effectiveness against challenging infections, including those caused by multi-drug resistant bacteria.


Su H. Wang, MD, MPH, FACP

Latest:

Science Is Science: Navigating Clinical Trust Amid Political Shifts

Su H Wang, MD, FACP, MPH discusses combating vaccine misinformation, preventing outbreaks, and highlighting global health interconnectedness


Aaron Hamby, PharmD

Latest:

Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public Health

Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.


Cheryl Wood, PharmD

Latest:

New Fecal Microbiota Options for Prevention of Recurrent Clostridioides difficile

With the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.


Louise-Marie Oleksiuk, PharmD, BCPS

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Johnathone Yang, DO

Latest:

The Final Antibiotic Symphony: Harmonizing Diagnostic Accuracy with Antibiotic Treatment in Native Joint Septic Arthritis

A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.


Mehrnaz Sadrolashrafi, PharmD, BCCCP

Latest:

COVID-19–Associated Fungal Infections During EMCO: Review of Epidemiology, Diagnosis, and Pharmacotherapy

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.


Zachary Hitchcock, PharmD Candidate; and J. Drew Zimmer, PharmD, BCPS, *SIDP

Latest:

Getting Help from HAL: Applying Machine Learning to Predict Antibiotic Resistance

A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.


Elliot DeHaan, MD

Latest:

Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59

Study results show that the vaccine elicits a comparable immune response in high-risk adults aged 18-59 with chronic medical conditions, suggesting potential for broader vaccination efforts.


Abigail Geyer, PharmD

Latest:

Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health Systems

As the first line of acute care, emergency departments are key stewards of antibiotics.


Cornelius (Neil) Clancy, MD

Latest:

Real-World Effectiveness of Cefiderocol in Treating Serious Gram-Negative Infections: Insights from the PROVE Study

Cornelius Clancy, MD, highlights the real-world outcomes of cefiderocol treatment for serious gram-negative bacterial infections, reporting a clinical success rate of 75% along with encouraging safety data.


Gregory P. Monohan, MD

Latest:

Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.




Lacy Worden, PharmD, BCIDP

Latest:

Emergency Department Antimicrobial Stewardship: A Critical Area of Focus for Health Systems

As the first line of acute care, emergency departments are key stewards of antibiotics.


Jason Hedvat, PharmD, BCIDP

Latest:

To Prophylax or not to Prophylax: Preventing CDI

Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).


Cara Slaton, PharmD

Latest:

STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis

New therapeutics offer some hope in this emerging market.


Kayla Stover, PharmD, BCIDP, BCPS, FCCP, FIDSA

Latest:

Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.


Brian Lu, PharmD

Latest:

Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.


Mollie Tucker, MD

Latest:

Mixed Fungal Brain Abscess

Clinicians review a patient case including diagnosis, treatment, and follow-up.


Zahra Qamar, MD; Steven F. Solga, MD; and Lisa A. Spacek, MD, PhD, FIDSA

Latest:

NAFLD Is Increasingly Affecting Patients With HIV

The prevalence of this disease in this patient population is much higher than in the general public.


Sonal Patel, PharmD, BCIDP

Latest:

SPREADing the Love: The Importance of Mentorship in Pharmacy

In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.


Esther Esadah, PharmD

Latest:

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.


Thomas Lodise, PharmD, PhD

Latest:

Advice for Physicians to Manage C. Difficile Infection (CDI)

Experts share advice for physicians taking care of patients with C. difficile infection (CDI).


Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD

Latest:

Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots

Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.


Killian Meara

Latest:

Reducing Long COVID Symptoms by Way of Vaccination

Research finds that individuals who received a COVID-19 vaccine more recently were less likely to develop long COVID.


Isabella Ciccone, MPH

Latest:

What We Know But Still Have to Learn About Long COVID

Despite advances in understanding and treating Long COVID, many questions about its mechanisms, susceptibility, and varied recovery patterns remain unresolved, underscoring the need for continued research.


James M. Crosby, DO

Latest:

Exploring the Recently Approved and Upcoming Clostridioides difficile Therapeutics

This market has seen a flurry of activity, as shown by a review of the latest agents.

© 2025 MJH Life Sciences

All rights reserved.